Universal Total Liab vs Accounts Payable Analysis

601231 Stock

14.89 0.30 1.97%

Universal Scientific financial indicator trend analysis is much more than just breaking down Universal Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Universal Scientific is a good investment. Please check the relationship between Universal Scientific Total Liab and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Accounts Payable

Total Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Universal Scientific Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Universal Scientific's Total Liab and Accounts Payable is 0.87. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Universal Scientific Industrial, assuming nothing else is changed. The correlation between historical values of Universal Scientific's Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Universal Scientific Industrial are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., Universal Scientific's Total Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Accounts Payable

An accounting item on the balance sheet that represents Universal Scientific obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Universal Scientific are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Universal Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Universal Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 277.3 M, whereas Selling General Administrative is forecasted to decline to about 340.4 M.

	2022	2023	2024	2025 (projected)
Operating Income	3.4B	2.5B	2.8B	3.0B
Total Revenue	68.5B	60.8B	69.9B	73.4B

Operating Income Total Revenue

Universal Scientific fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		-0.32	1.0	0.99	0.98	0.99	0.86	0.94	0.69	0.85	0.98	0.94	0.99	0.95	0.66	0.98	0.4	0.12	0.92	0.9	-0.92	0.92	0.93	0.81	0.89	0.82
Other Current Liab	-0.32		-0.37	-0.36	-0.24	-0.36	-0.05	-0.44	0.09	0.0	-0.29	-0.42	-0.28	-0.25	-0.01	-0.29	0.37	0.01	-0.35	-0.42	0.21	-0.55	-0.29	-0.09	-0.31	0.03
Total Current Liabilities	1.0	-0.37		0.99	0.96	0.99	0.83	0.96	0.65	0.82	0.96	0.96	0.99	0.94	0.63	0.97	0.33	0.11	0.91	0.91	-0.9	0.93	0.92	0.79	0.88	0.77
Total Stockholder Equity	0.99	-0.36	0.99		0.94	0.99	0.83	0.97	0.71	0.81	0.95	0.93	0.97	0.9	0.69	0.95	0.28	0.21	0.9	0.89	-0.91	0.93	0.89	0.81	0.84	0.75
Other Liab	0.98	-0.24	0.96	0.94		0.95	0.88	0.88	0.67	0.87	0.96	0.9	0.99	0.97	0.65	0.98	0.52	0.0	0.89	0.84	-0.89	0.83	0.92	0.8	0.91	0.84
Retained Earnings	0.99	-0.36	0.99	0.99	0.95		0.85	0.96	0.68	0.83	0.96	0.94	0.98	0.92	0.69	0.95	0.32	0.15	0.91	0.89	-0.92	0.93	0.91	0.82	0.86	0.78
Accounts Payable	0.86	-0.05	0.83	0.83	0.88	0.85		0.72	0.83	0.99	0.88	0.75	0.87	0.83	0.83	0.81	0.59	0.14	0.92	0.7	-0.9	0.7	0.93	0.92	0.87	0.86
Cash	0.94	-0.44	0.96	0.97	0.88	0.96	0.72		0.65	0.68	0.86	0.9	0.91	0.83	0.62	0.9	0.09	0.23	0.83	0.85	-0.84	0.92	0.82	0.72	0.79	0.6
Other Assets	0.69	0.09	0.65	0.71	0.67	0.68	0.83	0.65		0.78	0.68	0.5	0.66	0.57	0.92	0.63	0.36	0.51	0.68	0.5	-0.72	0.54	0.68	0.77	0.6	0.6
Net Receivables	0.85	0.0	0.82	0.81	0.87	0.83	0.99	0.68	0.78		0.88	0.75	0.87	0.85	0.78	0.81	0.65	0.08	0.91	0.72	-0.89	0.7	0.93	0.91	0.87	0.91
Inventory	0.98	-0.29	0.96	0.95	0.96	0.96	0.88	0.86	0.68	0.88		0.9	0.98	0.96	0.66	0.96	0.53	0.09	0.92	0.9	-0.9	0.9	0.94	0.81	0.89	0.89
Other Current Assets	0.94	-0.42	0.96	0.93	0.9	0.94	0.75	0.9	0.5	0.75	0.9		0.93	0.9	0.51	0.92	0.25	-0.02	0.86	0.88	-0.81	0.89	0.87	0.7	0.85	0.71
Total Liab	0.99	-0.28	0.99	0.97	0.99	0.98	0.87	0.91	0.66	0.87	0.98	0.93		0.98	0.64	0.98	0.48	0.06	0.92	0.9	-0.91	0.9	0.94	0.81	0.91	0.85
Intangible Assets	0.95	-0.25	0.94	0.9	0.97	0.92	0.83	0.83	0.57	0.85	0.96	0.9	0.98		0.52	0.98	0.57	-0.09	0.9	0.91	-0.85	0.86	0.93	0.74	0.94	0.87
Common Stock	0.66	-0.01	0.63	0.69	0.65	0.69	0.83	0.62	0.92	0.78	0.66	0.51	0.64	0.52		0.56	0.31	0.47	0.67	0.47	-0.77	0.54	0.65	0.83	0.55	0.58
Property Plant Equipment	0.98	-0.29	0.97	0.95	0.98	0.95	0.81	0.9	0.63	0.81	0.96	0.92	0.98	0.98	0.56		0.46	0.01	0.88	0.91	-0.84	0.88	0.91	0.73	0.92	0.8
Long Term Debt	0.4	0.37	0.33	0.28	0.52	0.32	0.59	0.09	0.36	0.65	0.53	0.25	0.48	0.57	0.31	0.46		-0.22	0.42	0.33	-0.44	0.18	0.5	0.44	0.51	0.76
Short Term Investments	0.12	0.01	0.11	0.21	0.0	0.15	0.14	0.23	0.51	0.08	0.09	-0.02	0.06	-0.09	0.47	0.01	-0.22		0.06	0.08	-0.24	0.16	0.03	0.14	-0.11	-0.14
Net Tangible Assets	0.92	-0.35	0.91	0.9	0.89	0.91	0.92	0.83	0.68	0.91	0.92	0.86	0.92	0.9	0.67	0.88	0.42	0.06		0.86	-0.89	0.87	0.99	0.85	0.95	0.81
Other Stockholder Equity	0.9	-0.42	0.91	0.89	0.84	0.89	0.7	0.85	0.5	0.72	0.9	0.88	0.9	0.91	0.47	0.91	0.33	0.08	0.86		-0.8	0.95	0.86	0.65	0.85	0.73
Deferred Long Term Liab	-0.92	0.21	-0.9	-0.91	-0.89	-0.92	-0.9	-0.84	-0.72	-0.89	-0.9	-0.81	-0.91	-0.85	-0.77	-0.84	-0.44	-0.24	-0.89	-0.8		-0.83	-0.89	-0.92	-0.81	-0.78
Short Long Term Debt	0.92	-0.55	0.93	0.93	0.83	0.93	0.7	0.92	0.54	0.7	0.9	0.89	0.9	0.86	0.54	0.88	0.18	0.16	0.87	0.95	-0.83		0.85	0.72	0.81	0.68
Total Current Assets	0.93	-0.29	0.92	0.89	0.92	0.91	0.93	0.82	0.68	0.93	0.94	0.87	0.94	0.93	0.65	0.91	0.5	0.03	0.99	0.86	-0.89	0.85		0.84	0.97	0.84
Short Term Debt	0.81	-0.09	0.79	0.81	0.8	0.82	0.92	0.72	0.77	0.91	0.81	0.7	0.81	0.74	0.83	0.73	0.44	0.14	0.85	0.65	-0.92	0.72	0.84		0.75	0.81
Non Current Assets Total	0.89	-0.31	0.88	0.84	0.91	0.86	0.87	0.79	0.6	0.87	0.89	0.85	0.91	0.94	0.55	0.92	0.51	-0.11	0.95	0.85	-0.81	0.81	0.97	0.75		0.79
Non Currrent Assets Other	0.82	0.03	0.77	0.75	0.84	0.78	0.86	0.6	0.6	0.91	0.89	0.71	0.85	0.87	0.58	0.8	0.76	-0.14	0.81	0.73	-0.78	0.68	0.84	0.81	0.79

Click cells to compare fundamentals

Universal Scientific Account Relationship Matchups

Universal Scientific fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	31.0B	35.9B	38.6B	39.3B	45.2B	47.5B
Other Current Liab	826.9M	1.3B	3.7M	3.9M	3.6M	3.4M
Total Current Liabilities	14.9B	17.6B	18.7B	21.2B	24.4B	25.6B
Total Stockholder Equity	12.1B	13.1B	15.7B	17.0B	19.5B	20.5B
Other Liab	144.8M	223.2M	560.4M	516.6M	594.1M	623.8M
Retained Earnings	7.9B	8.6B	10.3B	11.2B	12.9B	13.5B
Accounts Payable	11.2B	11.5B	11.1B	10.6B	12.2B	6.6B
Cash	6.3B	6.0B	7.7B	11.2B	12.9B	13.5B
Other Assets	608.4M	535.1M	647.7M	690.9M	794.5M	404.0M
Net Receivables	10.5B	12.5B	11.1B	10.0B	11.5B	6.6B
Inventory	6.8B	9.0B	10.9B	8.3B	9.6B	10.0B
Other Current Assets	508.5M	588.2M	599.9M	838.4M	964.1M	1.0B
Total Liab	18.9B	22.8B	22.8B	22.2B	25.5B	26.8B
Intangible Assets	290.4M	453.5M	415.1M	368.3M	423.5M	444.7M
Property Plant Equipment	1.6B	2.5B	4.0B	4.8B	5.5B	5.8B
Long Term Debt	3.0B	4.2B	3.3B	47.1M	54.1M	51.4M
Net Tangible Assets	10.1B	10.9B	12.1B	13.9B	15.9B	10.9B
Other Stockholder Equity	(44.3M)	6.9M	(91.2M)	326.3M	375.2M	394.0M
Deferred Long Term Liab	301.2M	286.1M	250.5M	227.6M	204.8M	227.5M
Short Long Term Debt	375.3M	2.5B	4.5B	4.4B	5.0B	5.3B
Total Current Assets	24.6B	28.5B	30.9B	31.0B	35.6B	23.3B
Non Current Assets Total	6.4B	7.4B	7.7B	8.3B	9.6B	5.6B
Non Currrent Assets Other	89.8M	136.8M	124.6M	68.3M	78.5M	81.6M
Non Current Liabilities Total	4.0B	5.2B	4.1B	1.0B	1.2B	2.1B
Non Current Liabilities Other	16.3M	61.3M	11.0M	74.9M	86.1M	90.4M
Common Stock Shares Outstanding	2.2B	2.2B	2.2B	2.2B	2.5B	2.4B
Net Invested Capital	15.4B	19.8B	23.6B	21.4B	24.6B	17.7B
Net Working Capital	9.7B	10.9B	12.1B	9.8B	11.2B	10.0B
Capital Stock	2.2B	2.2B	2.2B	2.2B	2.5B	2.4B
Property Plant And Equipment Net	3.7B	4.8B	5.2B	5.9B	6.8B	4.9B
Good Will	1.1B	559.0M	576.7M	607.7M	698.9M	630.7M
Capital Lease Obligations	535.0M	475.1M	381.7M	486.8M	438.1M	379.6M
Property Plant And Equipment Gross	7.6B	9.3B	5.2B	5.9B	5.4B	5.5B

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Universal Stock

Balance Sheet is a snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Universal Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Universal Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Universal currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Universal Total Liab vs Accounts Payable Analysis

Total Liab vs Accounts Payable

Total Liab vs Accounts Payable Correlation Analysis

Correlation Coefficient

Total Liab

Accounts Payable

Universal Scientific fundamental ratios Correlations

Universal Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Universal Scientific fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Total Stockholder Equity	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Stockholder Equity	+ 0.99	Total Current Liabilities
Retained Earnings	+ 0.99	Total Current Liabilities

Short Term Debt	- 0.92	Deferred Long Term Liab
Deferred Long Term Liab	- 0.92	Retained Earnings
Deferred Long Term Liab	- 0.92	Total Assets
Deferred Long Term Liab	- 0.91	Total Liab
Deferred Long Term Liab	- 0.91	Total Stockholder Equity
Deferred Long Term Liab	- 0.9	Inventory